Diarrhea Current Events | Diarrhea News | 3
|
|
|
Sort By:
Page Views | Date |
New data at ASCO show CAMPTOSAR is key to treating 1st line metastatic colorectal cancer
Data presented today at the annual meeting of the American Society of Clinical Oncology (ASCO) demonstrated that CAMPTOSAR® (irinotecan HCL injection), when given in the infusional regimen FOLFIRI , provided statistically significant longer progression free survival (PFS) compared to bolus mIFL and CapeIRI , two alternative chemotherapeutic... view more... (2006-06-06)
US adults now discovering the secrets of probiotics
Probiotic supplements have been used around the world for at least half a century, but almost half (49 percent) of Americans indicate that they have never heard of them, according to a recent survey conducted by Harris Interactive® for Florastor®, the world's top-selling probiotic, now being launched widely in the United States. view more (2007-03-13)
Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence
C. diff-associated disease (CDAD), otherwise known as severe intestinal disease brought on by the Clostridium difficile (C. diff) pathogen, has been the subject of heightened concern in the medical community. view more (2008-04-30)
IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. view more (2006-11-06)
Peptide discovered in scorpion venom may hold key to secretory diseases
Researchers have discovered a peptide in scorpion venom that may hold the key to understanding and controlling cystic fibrosis and other secretory diseases. view more (2008-02-15)
Mayo Clinic discovers potential link between celiac disease and cognitive decline
Mayo Clinic researchers have uncovered a new link between celiac disease, a digestive condition triggered by consumption of gluten, and dementia or other forms of cognitive decline. view more (2006-10-10)
Is re-emerging superbug the next MRSA?
Loyola physicians warn little-known bacteria Clostridium difficile next emerging disease threat, killing 1,000s in the United State. view more (2008-09-16)
Drug brings relief for many IBS patients who experience constipation
Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS. view more (2008-05-19)
St. Jude shows gene test not needed if cancer drug given in low doses
Investigators at St. Jude Children's Research Hospital have shown that when the cancer drug irinotecan is given in low doses for multiple days, it eliminates the need to delay treatment to perform costly genetic testing that determines if the patient is at risk for serious treatment side effects, such as neutropenia. view more (2007-06-20)
Breastfed babies breathe better, except when mom has asthma
When it comes to feeding babies, the old adage "breast is best" certainly holds true, with breastfed babies having less diarrhea and fewer ear infections and incidents of wheezing in early life. view more (2007-11-01)
Review of probiotic trial research finds only Bifantis able to claim efficacy for IBS symptoms
A review by researchers at Northwestern University (Chicago, IL.) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve... view more... (2009-03-23)
Small molecule inhibitor of cholera discovered
Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria. view more (2005-10-17)
Would you like fries with that?
Exploiting interactions between food and drugs could dramatically lower the rapidly rising costs of several anticancer drugs, and perhaps many other medications, two cancer-pharmacology specialists suggest in a commentary in the July 16, 2007, issue of the Journal of Clinical Oncology. view more (2007-07-17)
Smokers have worse side effects from radiation treatment for prostate cancer
Smoking has been found to contribute to poorer outcomes for people treated for many kinds of cancer and now, researchers at Fox Chase Cancer Center have associated smoking and acute side-effects following radiation therapy for prostate cancer. view more (2006-11-06)
Transplant rejection drug holds promise for inflammatory eye disease
The immunosuppressive drug mycophenolate mofetil, used to prevent rejection of transplanted hearts, kidneys and livers, may also be effective in controlling inflammatory eye diseases. view more (2005-09-02)
Cholera vaccine could protect affected communities
A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas. view more (2007-11-27)
Weighing costs, benefits of HIV treatments
Prevention versus treatment? Cost versus efficacy? So go two of the dilemmas looming over Dartmouth's Paul E. Palumbo, M.D., and his fellow researchers in the race to fight HIV and other infectious diseases in the developing world - especially among women and their young children. view more (2009-09-16)
Susceptibility to Crohn's disease — an important new clue
Crohn's disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. view more (2007-04-23)
New intestinal disease charted by Swedish researcher
Microscopic colitis is a newly discovered inflammatory intestinal disease that occurs in two different forms, lymphocytary colitis and collagenic colitis. Ã-rebro University, Sweden, is on the cutting edge of research on these diseases, and Martin Olesen is one of first scientists in the country to write a dissertation on the subject, defending... view more... (2004-01-26)
New vaccine could prevent condition that causes 500,000 infant deaths a year worldwide
In a new study of more than 68,000 infants published in this week's New England Journal of Medicine, the investigational vaccine Rotateq demonstrated that it can safely prevent 98 percent of severe cases of viral diarrhea and vomiting that account for 2 million hospital visits and 500,000 pediatric deaths each year worldwide. view more (2006-01-05)
|
|
|
|
Sort By:
Page Views | Date |
|
